Consensus Statement from India on the Renal Benefits of ARNi, SGLT-2i, and Bisoprolol in Chronic Kidney Disease.
Chopra HK, Khullar D, Nair T, Wander GS, Ponde CK, Ray S, Nanda NC, Kasliwal RR, Rana DS, Kirpalani A, Sawhney J, Chandra P, Mehta Y, Kumar V, Tewari S, Pancholia AK, Kher V, Bansal S, Mittal S, Kerkar P, Sahoo PK, Hotchandani R, Prakash S, Chauhan N, Rastogi V, Jabir A, Shanmugasundaram S, Tiwaskar M, Sinha A, Gupta V, Mishra SS, Routray SN, Omar AK, Swami OC, Jaswal A, Alam S, Passey R, Rajput R, Paul J, Kapoor A, Prabhakar D, Chandra S, Malhotra P, Singh VP, Bansal M, Shah P, Jain S, Bhargava M, Vijayalakshmi IB, Varghaese K, Jain D, Goel A, Gaur N, Tandon R, Moorthy A, George S, Katyal VK, Mantri RR, Mehrotra R, Bhalla D, Mittal V, Rao S, Jagia M, Singh H, Awasthi S, Sattur A, Mishra R, Pandey A, Chawla R, Jaggi S, Sehgal B, Sehgal A, Goel N, Gupta R, Kubba S, Chhabra A, Bagga S, Shastry NR.
Chopra HK, et al. Among authors: sawhney j.
J Assoc Physicians India. 2024 May;72(5):77-88. doi: 10.59556/japi.72.0543.
J Assoc Physicians India. 2024.
PMID: 38881115